×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Neuropathology Market Size

ID: MRFR/Pharma/3543-HCR
100 Pages
Rahul Gotadki
October 2025

Neuropathology Market Research Report By Diagnosis (Biopsy, Body Fluids, Peripheral Blood Smears, others), Application (Cerebral Hypoxia & Stroke, Perinatal Disorders, CNS Infections, Demyelinative Diseases, others), End User– Global Forecast till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Neuropathology Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Neuropathology Size

Neuropathology Market Growth Projections and Opportunities

A key market factor is the number of people who get neuropathological illnesses. As the number of cases rises, we need better diagnosis tools, medicines, and treatments. More findings could help the market grow. Innovations in imaging and biomarkers have changed neuropathology. Treatment results are better when diagnosed early and correctly, which affects the market for goods that are linked. New neuropathology therapies are made possible by research and development at universities and pharmaceutical companies. The market is affected by the creation of new drugs, therapies, and fixes for brain diseases. There are a lot of strict rules and regulations that affect the neuropathology market. The governing system affects the creation, production, and sale of drugs and therapeutic uses. It also sets the playing field for competition and makes the market accessible. The neuropathology business is helped by new healthcare buildings and equipment. Neuropathological diagnosis and treatment are more popular in places with well-established medical services. Knowing about brain illnesses and how to spot them early may help doctors find and treat them. Patient instruction programs encourage responsible health care, which has an effect on the market by encouraging early action. The market depends on the prices of drugs and therapies used to treat neuropathologies. Patients' access to drugs is affected by cost and insurance coverage, which in turn impacts market demand. Neuropathology has made it possible to treat brain diseases more precisely by learning about their genetic causes. Customizing drugs to each patient's genetic trait could have an effect on the market by making therapy more focused and successful. In neuropathology research and development, pharmaceutical businesses, study institutions, and healthcare workers work together to find ways to make things better. Partnerships can change the way markets work and lead to the development of new medicines and testing tools. The neuropathology market is affected by GDP and healthcare spending. When economies are strong, people may spend more on health care, which means that neuropathological treatments need to be more advanced. Neuropathology detection and treatment are changed by telemedicine, AI, and digital health solutions. Market trends are changed by technological progress that makes healthcare more accessible and more efficient.

Neuropathology Market Size Graph
Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

Leave a Comment

FAQs

At what CAGR is the neuropathology market projected to grow during the forecast period?

Neuropathology market is projected to grow at a 8.14% CAGR between 2024- 2032.

Which region is expected to dominate the neuropathology market?

North America is expected to dominate the neuropathology market.

Name the major end users of the neuropathology market.

Research centers, clinics, hospitals, and others are the major end users of the neuropathology market.

What are the key factors driving the neuropathology market?

Technological advances in medical diagnostic devices and rising prevalence of musculoskeletal conditions are the key factors driving the neuropathology market.

Who are the leading players profiled in the neuropathology market?

Leading players profiled in the neuropathology market include NeoGenomics Laboratories, Agilent Technologies Inc., Quest Diagnostics Incorporated, Danaher Corporation, Sakura Finetek USA Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Abbott Laboratories, Therapath LLC, and ARUP Laboratories.

Market Summary

As per MRFR analysis, the Neuropathology Market Size was estimated at 2735.45 USD Million in 2024. The Neuropathology industry is projected to grow from 2968.95 USD Million in 2025 to 6018.59 USD Million by 2035, exhibiting a compound annual growth rate (CAGR) of 7.39 during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Neuropathology Market is experiencing robust growth driven by technological advancements and increasing demand for personalized medicine.

  • Technological advancements in diagnostics are reshaping the landscape of neuropathology, particularly in North America.
  • The rise of personalized medicine is fostering innovative approaches in both diagnostic testing and research and development segments.
  • Collaborative research initiatives are gaining momentum, especially in the Asia-Pacific region, enhancing the speed of discovery.
  • The increasing prevalence of neurological disorders and advancements in biomarker discovery are key drivers propelling market expansion.

Market Size & Forecast

2024 Market Size 2735.45 (USD Million)
2035 Market Size 6018.59 (USD Million)
CAGR (2025 - 2035) 7.39%
Largest Regional Market Share in 2024 North America

Major Players

<p>Roche (CH), Abbott (US), Thermo Fisher Scientific (US), Siemens Healthineers (DE), Philips (NL), GE Healthcare (US), Bristol-Myers Squibb (US), Merck KGaA (DE), Agilent Technologies (US), F. Hoffmann-La Roche (CH)</p>

Market Trends

The Neuropathology Market is currently experiencing a dynamic evolution, driven by advancements in diagnostic technologies and an increasing prevalence of neurological disorders. The integration of artificial intelligence and machine learning into pathology practices appears to enhance diagnostic accuracy and efficiency, potentially transforming traditional methodologies. Furthermore, the growing emphasis on personalized medicine suggests a shift towards tailored therapeutic approaches, which may lead to improved patient outcomes. As research continues to uncover the complexities of neurological diseases, the demand for specialized neuropathological services is likely to rise, indicating a robust growth trajectory for the market. In addition, the Neuropathology Market is witnessing a surge in collaborative efforts among academic institutions, healthcare providers, and industry stakeholders. These partnerships seem to foster innovation and expedite the development of novel diagnostic tools and treatment modalities. Moreover, the increasing focus on early detection and intervention strategies may further propel market expansion. Overall, the Neuropathology Market appears poised for significant advancements, driven by technological innovations and a deeper understanding of neurological conditions.

Technological Advancements in Diagnostics

The Neuropathology Market is increasingly influenced by the integration of cutting-edge technologies. Innovations such as digital pathology and artificial intelligence are enhancing diagnostic capabilities, allowing for more precise and timely identification of neurological disorders. This trend suggests a potential shift in how neuropathological assessments are conducted, with technology playing a pivotal role in improving patient care.

Rise of Personalized Medicine

There is a growing emphasis on personalized medicine within the Neuropathology Market. Tailoring treatment plans to individual patient profiles appears to be gaining traction, as it may lead to more effective therapeutic outcomes. This trend indicates a broader movement towards understanding the unique genetic and molecular characteristics of neurological diseases, which could reshape treatment paradigms.

Collaborative Research Initiatives

The Neuropathology Market is characterized by an increase in collaborative research initiatives among various stakeholders. Partnerships between academic institutions, healthcare organizations, and industry players seem to be fostering innovation and accelerating the development of new diagnostic tools and therapies. This trend highlights the importance of collective efforts in advancing the field of neuropathology.

Neuropathology Market Market Drivers

Aging Population

The aging population is a critical factor influencing the Global Neuropathology Market Industry. As life expectancy increases globally, the proportion of elderly individuals is rising, leading to a higher incidence of age-related neurological disorders. This demographic shift is prompting healthcare systems to adapt and expand their services to meet the needs of this population. For example, countries with rapidly aging populations are witnessing a surge in demand for neuropathological assessments and interventions. Consequently, the Global Neuropathology Market Industry is expected to grow substantially, with estimates suggesting it will reach 3.26 USD Billion in 2024, reflecting the urgent need for specialized care.

Market Growth Projections

The Global Neuropathology Market Industry is anticipated to experience robust growth over the next decade. Projections indicate that the market will expand from 3.26 USD Billion in 2024 to an impressive 9.79 USD Billion by 2035. This growth trajectory suggests a compound annual growth rate of 10.51% from 2025 to 2035. Factors contributing to this expansion include advancements in diagnostic technologies, increasing prevalence of neurological disorders, and heightened research funding. The market's evolution is likely to be shaped by ongoing innovations and a growing emphasis on personalized medicine, which may further enhance the efficacy of neuropathological interventions.

Increased Research Funding

The surge in research funding from both public and private sectors is significantly impacting the Global Neuropathology Market Industry. Governments and organizations are increasingly investing in research initiatives aimed at understanding the complexities of neurological diseases. For instance, the National Institutes of Health (NIH) has allocated substantial resources to research on neurodegenerative disorders. This influx of funding not only supports the development of new diagnostic and therapeutic approaches but also fosters collaboration among researchers and institutions. As a result, the Global Neuropathology Market Industry is likely to benefit from enhanced innovation and discovery, contributing to its projected growth to 9.79 USD Billion by 2035.

Growing Awareness and Education

There is a growing awareness and education regarding neurological disorders among healthcare professionals and the general public, which is driving the Global Neuropathology Market Industry. Initiatives aimed at educating clinicians about the latest advancements in neuropathology are becoming more prevalent. Additionally, public health campaigns are raising awareness about the importance of early diagnosis and treatment of neurological conditions. This increased knowledge is likely to lead to higher demand for neuropathological services and products. As a result, the Global Neuropathology Market Industry is poised for growth, with projections indicating a significant expansion in the coming years.

Rising Prevalence of Neurological Disorders

The increasing incidence of neurological disorders, such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis, is a primary driver of the Global Neuropathology Market Industry. As the global population ages, the prevalence of these conditions is expected to rise significantly. For instance, it is estimated that by 2035, the number of individuals suffering from dementia will reach 115 million worldwide. This growing patient population necessitates advanced diagnostic and therapeutic solutions, thereby propelling the market forward. The Global Neuropathology Market Industry is projected to reach 3.26 USD Billion in 2024, reflecting the urgent need for innovative neuropathological assessments.

Technological Advancements in Diagnostic Tools

Technological innovations in diagnostic tools, such as advanced imaging techniques and molecular pathology, are transforming the landscape of the Global Neuropathology Market Industry. These advancements enhance the accuracy and speed of diagnoses, allowing for earlier intervention and improved patient outcomes. For example, the integration of artificial intelligence in imaging analysis is showing promise in identifying subtle changes in brain pathology. As these technologies become more widely adopted, they are likely to drive market growth. The Global Neuropathology Market Industry is expected to experience a compound annual growth rate of 10.51% from 2025 to 2035, indicating a robust demand for cutting-edge diagnostic solutions.

Market Segment Insights

By Application: Diagnostic Testing (Largest) vs. Research and Development (Fastest-Growing)

<p>In the Neuropathology Market, the application segment is primarily dominated by Diagnostic Testing, which holds the largest share. This segment benefits from the increasing prevalence of neurological disorders, resulting in a surge in demand for efficient diagnostic solutions. On the other hand, Research and Development is rapidly gaining momentum as more organizations invest in understanding neurological diseases, aligning with emerging technologies and novel therapeutic approaches. The growth trends in this segment are driven by advancements in technology and an increasing focus on personalized medicine. The rise in awareness regarding early detection and treatment of neurological disorders further fuels the expansion of Diagnostic Testing. Conversely, the R&D sector is being transformed by innovation, with a robust emphasis on developing targeted therapies and precision diagnostics.</p>

<p>Diagnostic Testing: Dominant vs. Therapeutic Applications: Emerging</p>

<p>Diagnostic Testing is characterized by its critical role in identifying various neurological disorders, thereby playing a crucial part in patient management and treatment planning. Its key features include advanced imaging techniques, biomarker discovery, and the integration of AI-driven solutions to enhance accuracy. Conversely, Therapeutic Applications are emerging with a focus on the development of innovative treatments targeting specific conditions. This segment includes advancements in neuropharmacology and biologics, which are crucial for creating effective therapeutic strategies. It reflects the growing need for tailored therapies that improve patient outcomes and quality of life. Both segments demonstrate significant importance in the overall landscape of neuropathology, but each caters to distinct yet complementary needs within this market.</p>

By End Use: Hospitals (Largest) vs. Diagnostic Laboratories (Fastest-Growing)

<p>In the Neuropathology Market, a significant share is held by hospitals, which serve as primary centers for diagnosing and managing neurological disorders. With advanced facilities, hospitals leverage neuropathological services for both patient diagnosis and treatment, contributing to their dominant market presence. Meanwhile, diagnostic laboratories also play a pivotal role, specializing in providing precise and timely tests essential for neuropathological evaluations, thus forming a critical aspect of the healthcare continuum.</p>

<p>Hospitals (Dominant) vs. Diagnostic Laboratories (Emerging)</p>

<p>Hospitals remain the dominant players in the Neuropathology Market, characterized by extensive resources and specialized departments dedicated to neurological studies. Their capacity to invest in cutting-edge technologies and skilled personnel enables them to enhance diagnostic accuracy and improve patient outcomes. On the other hand, diagnostic laboratories are emerging rapidly, driven by the demand for specialized testing. These laboratories focus on efficiency and accuracy, adopting advanced diagnostic tools to meet the growing needs of healthcare providers. Their flexibility and specialization position them to capture a larger share as the focus on precise diagnostics intensifies.</p>

By Product Type: Immunohistochemistry Kits (Largest) vs. Staining Reagents (Fastest-Growing)

<p>The Neuropathology Market exhibits distinct differences in market share distribution across its product types. Immunohistochemistry Kits dominate this segment as the largest contributor, reflecting their essential role in diagnosing and researching neurological disorders. In contrast, Staining Reagents, while less dominant, are experiencing rapid growth, highlighting their increasing importance in neuropathological diagnostics as new staining techniques emerge and gain acceptance.</p>

<p>Immunohistochemistry Kits (Dominant) vs. Staining Reagents (Emerging)</p>

<p>Immunohistochemistry Kits are at the forefront of the Neuropathology Market, characterized by their comprehensive range and high specificity for various biomarkers. Their dominant position stems from the increasing prevalence of neurological disorders, leading to a surge in diagnostic procedures. Meanwhile, Staining Reagents are positioned as an emerging segment, driven by innovations in staining technology and heightened demand for accurate and reliable diagnostic results. The growth in Staining Reagents is significantly influenced by the rising focus on research activities and advancements in technical solutions, thus promising a robust future in neuropathology.</p>

By Technology: Molecular Diagnostics (Largest) vs. Next Generation Sequencing (Fastest-Growing)

<p>The Neuropathology Market is experiencing a significant shift towards advanced technologies, with Molecular Diagnostics holding the largest market share. This segment encompasses a range of techniques that allow for the precise detection of biomarkers associated with neurological conditions. Following closely is Histopathology, which remains a cornerstone of neuropathological analysis, while Immunohistochemistry plays a crucial role in identifying specific antigens in tissue samples, facilitating accurate diagnoses. In contrast, Next Generation Sequencing (NGS) is emerging as the fastest-growing segment within this market. The increased adoption of NGS can be attributed to its ability to provide comprehensive insights into genetic variations and mutations associated with neurodegenerative diseases. Additionally, advancements in sequencing technology and decreasing costs are driving its rapid growth, positioning it as a key player in the future of neuropathology diagnostics.</p>

<p>Technology: Molecular Diagnostics (Dominant) vs. Next Generation Sequencing (Emerging)</p>

<p>Molecular Diagnostics is the dominant force in the Neuropathology Market, characterized by its precision and ability to detect genetic and molecular changes in neurological disorders. This segment benefits from a wide range of applications, including the diagnosis of various neurodegenerative diseases, making it essential for pathologists. Its established methodologies and continuous evolution are critical for enhancing diagnostic accuracy. On the other hand, Next Generation Sequencing is positioned as an emerging technology, offering innovative approaches to understanding the genetic landscape of neuropathological conditions. With its capability to analyze multiple genes simultaneously and its growing accessibility, NGS is set to revolutionize how neuropathologists evaluate complex diseases, fostering personalized treatment strategies.</p>

Get more detailed insights about Neuropathology Market Research Report- Global Forecast till 2035

Regional Insights

North America : Market Leader in Neuropathology

North America continues to lead the neuropathology market, holding a significant share of $1365.0M in 2024. The growth is driven by increasing prevalence of neurological disorders, advancements in diagnostic technologies, and supportive regulatory frameworks. The region's robust healthcare infrastructure and high R&D investments further catalyze market expansion, making it a focal point for innovation in neuropathology. The United States is the primary contributor, with key players like Roche, Abbott, and Thermo Fisher Scientific dominating the landscape. The competitive environment is characterized by continuous product development and strategic partnerships. The presence of advanced healthcare facilities and a strong emphasis on research and development solidify North America's position as a leader in the neuropathology market.

Europe : Emerging Market with Growth Potential

Europe's neuropathology market is valued at $850.0M, reflecting a growing demand for advanced diagnostic solutions. Factors such as an aging population, rising awareness of neurological diseases, and regulatory support for innovative therapies are driving this growth. The European Medicines Agency (EMA) plays a crucial role in facilitating market access for new treatments, enhancing the region's attractiveness for investment. Germany, France, and the UK are leading countries in this market, with significant contributions from companies like Siemens Healthineers and Merck KGaA. The competitive landscape is marked by collaborations between public and private sectors, fostering innovation. The presence of established healthcare systems and a focus on research further enhance Europe's position in The Neuropathology.

Asia-Pacific : Rapidly Growing Market Segment

The Asia-Pacific neuropathology market, valued at $450.0M, is witnessing rapid growth driven by increasing healthcare expenditure and rising incidences of neurological disorders. The region's expanding population and improving healthcare infrastructure are key factors contributing to this upward trend. Additionally, government initiatives aimed at enhancing healthcare access are expected to further stimulate market growth in the coming years. Countries like China, Japan, and India are at the forefront of this market, with significant investments from local and international players. Companies such as GE Healthcare and Agilent Technologies are actively expanding their presence in the region. The competitive landscape is evolving, with a focus on innovative diagnostic solutions and strategic partnerships to meet the growing demand for neuropathology services.

Middle East and Africa : Emerging Market with Challenges

The Middle East and Africa neuropathology market is valued at $70.45M, reflecting a nascent but growing segment. The market is driven by increasing awareness of neurological disorders and the need for advanced diagnostic tools. However, challenges such as limited healthcare infrastructure and regulatory hurdles may impede growth. Nonetheless, government initiatives aimed at improving healthcare access are expected to foster market development in the region. South Africa and the UAE are leading countries in this market, with a growing presence of international players. Companies are focusing on establishing partnerships with local healthcare providers to enhance service delivery. The competitive landscape is characterized by a mix of established firms and emerging players, all striving to capture a share of this developing market.

Key Players and Competitive Insights

The Neuropathology Market is characterized by a dynamic competitive landscape, driven by advancements in diagnostic technologies and an increasing prevalence of neurological disorders. Key players such as Roche (CH), Abbott (US), and Thermo Fisher Scientific (US) are strategically positioned to leverage innovation and partnerships to enhance their market presence. Roche (CH) focuses on integrating digital solutions into its diagnostic platforms, while Abbott (US) emphasizes the development of point-of-care testing technologies. Thermo Fisher Scientific (US) is actively pursuing collaborations with research institutions to advance biomarker discovery, thereby shaping a competitive environment that prioritizes technological advancement and strategic alliances.

In terms of business tactics, companies are increasingly localizing manufacturing to reduce supply chain vulnerabilities and optimize operational efficiency. The market appears moderately fragmented, with a mix of established players and emerging companies vying for market share. The collective influence of these key players fosters a competitive structure that encourages innovation and responsiveness to market demands.

In November 2025, Roche (CH) announced a partnership with a leading AI firm to enhance its neuropathology diagnostic capabilities. This collaboration aims to integrate machine learning algorithms into Roche's existing platforms, potentially improving diagnostic accuracy and speed. Such a strategic move underscores Roche's commitment to innovation and positions it favorably in a market that increasingly values technological integration.

In October 2025, Abbott (US) launched a new portable diagnostic device specifically designed for rapid neurological assessments. This device is expected to facilitate timely decision-making in clinical settings, reflecting Abbott's focus on point-of-care solutions. The introduction of this technology may significantly enhance patient outcomes and solidify Abbott's competitive edge in the market.

In September 2025, Thermo Fisher Scientific (US) expanded its product portfolio by acquiring a startup specializing in advanced imaging technologies for neuropathology. This acquisition is likely to enhance Thermo Fisher's capabilities in providing comprehensive diagnostic solutions, thereby reinforcing its market position. The strategic importance of this move lies in the potential for improved diagnostic precision and the ability to offer integrated solutions to healthcare providers.

As of December 2025, current competitive trends in the Neuropathology Market are heavily influenced by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise. Looking ahead, competitive differentiation is expected to evolve, with a shift from price-based competition to a focus on innovation, technological advancements, and supply chain reliability. This transition may redefine market dynamics, emphasizing the importance of strategic partnerships and cutting-edge solutions in maintaining a competitive advantage.

Key Companies in the Neuropathology Market market include

Industry Developments

Future Outlook

Neuropathology Market Future Outlook

<p>The Neuropathology Market is projected to grow at a 7.39% CAGR from 2024 to 2035, driven by advancements in diagnostic technologies, increasing prevalence of neurological disorders, and rising healthcare expenditure.</p>

New opportunities lie in:

  • <p>Development of AI-driven diagnostic tools for early detection of neuropathological conditions.</p>
  • <p>Expansion of telepathology services to enhance remote diagnostics and consultations.</p>
  • <p>Investment in biomarker research for personalized treatment strategies in neuropathology.</p>

<p>By 2035, the Neuropathology Market is expected to achieve substantial growth, reflecting evolving healthcare needs and technological advancements.</p>

Market Segmentation

Neuropathology Market End Use Outlook

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutions
  • Pharmaceutical Companies

Neuropathology Market Technology Outlook

  • Molecular Diagnostics
  • Histopathology
  • Immunohistochemistry
  • Next Generation Sequencing

Neuropathology Market Application Outlook

  • Diagnostic Testing
  • Research and Development
  • Therapeutic Applications
  • Forensic Analysis

Neuropathology Market Product Type Outlook

  • Staining Reagents
  • Immunohistochemistry Kits
  • Microscopes
  • Digital Pathology Solutions

Report Scope

MARKET SIZE 20242735.45(USD Million)
MARKET SIZE 20252968.95(USD Million)
MARKET SIZE 20356018.59(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)7.39% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Million
Key Companies ProfiledRoche (CH), Abbott (US), Thermo Fisher Scientific (US), Siemens Healthineers (DE), Philips (NL), GE Healthcare (US), Bristol-Myers Squibb (US), Merck KGaA (DE), Agilent Technologies (US), F. Hoffmann-La Roche (CH)
Segments CoveredApplication, End Use, Product Type, Technology
Key Market OpportunitiesAdvancements in digital pathology and artificial intelligence enhance diagnostic accuracy in the Neuropathology Market.
Key Market DynamicsRising demand for advanced diagnostic techniques drives innovation and competition in the neuropathology market.
Countries CoveredNorth America, Europe, APAC, South America, MEA

FAQs

At what CAGR is the neuropathology market projected to grow during the forecast period?

Neuropathology market is projected to grow at a 8.14% CAGR between 2024- 2032.

Which region is expected to dominate the neuropathology market?

North America is expected to dominate the neuropathology market.

Name the major end users of the neuropathology market.

Research centers, clinics, hospitals, and others are the major end users of the neuropathology market.

What are the key factors driving the neuropathology market?

Technological advances in medical diagnostic devices and rising prevalence of musculoskeletal conditions are the key factors driving the neuropathology market.

Who are the leading players profiled in the neuropathology market?

Leading players profiled in the neuropathology market include NeoGenomics Laboratories, Agilent Technologies Inc., Quest Diagnostics Incorporated, Danaher Corporation, Sakura Finetek USA Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Abbott Laboratories, Therapath LLC, and ARUP Laboratories.

  1. Definition
    1. Scope of the Study
      1. Research Objective
      2. Assumptions
      3. Limitations
    2. Introduction
    3. Primary Research
    4. Secondary research
    5. Market Size Estimation
    6. Drivers
    7. Restrains
    8. Opportunities
    9. Challenges
    10. Macroeconomic Indicators
    11. Technology Trends & Assessment
    12. Porter’s Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of New Entrants
      4. Threat of Substitutes
      5. Intensity of Rivalry
    13. Value Chain Analysis
    14. Investment Feasibility Analysis
    15. Pricing Analysis
  2. Chapter 6. Global Neuropathology Market, by Diagnosis Test
    1. Introduction
    2. Biopsy
      1. Market Estimates & Forecast, 2020 – 2027
    3. Body fluids
      1. Market Estimates & Forecast, 2020 – 2027
    4. Peripheral blood smears
      1. Market Estimates & Forecast, 2020 – 2027
    5. Biopsy
      1. Market Estimates & Forecast, 2020 – 2027
    6. Tissue resections
      1. Market Estimates & Forecast, 2020 – 2027
    7. Others
      1. Market Estimates & Forecast, 2020 – 2027
  3. Chapter 7. Global Neuropathology Market, by Application
    1. Introduction
    2. Cerebral hypoxia and stroke
      1. Market Estimates & Forecast, 2020 – 2027
    3. Perinatal disorders
      1. Market Estimates & Forecast, 2020 – 2027
    4. CNS infections
      1. Market Estimates & Forecast, 2020 – 2027
    5. Demyelinative diseases
      1. Market Estimates & Forecast, 2020 – 2027
    6. Brain tumors
      1. Market Estimates & Forecast, 2020 – 2027
    7. Neurodegenerative diseases
      1. Market Estimates & Forecast, 2020 – 2027
    8. Inherited metabolic disorders
      1. Market Estimates & Forecast, 2020 – 2027
    9. Peripheral neuropathy
      1. Market Estimates & Forecast, 2020 – 2027
    10. Myopathology
      1. Market Estimates & Forecast, 2020 – 2027
    11. Others
  4. Chapter 8. Global Neuropathology Market, by End User
    1. Introduction
    2. Hospitals
      1. Market Estimates & Forecast, 2020 – 2027
    3. Clinics
      1. Market Estimates & Forecast, 2020 – 2027
    4. Research centers
      1. Market Estimates & Forecast, 2020 – 2027
    5. Others
      1. Market Estimates & Forecast, 2020 – 2027
  5. Chapter .9 Global Neuropathology Market, by Region
    1. Introduction
    2. Americas
      1. North America
      2. South America
    3. Europe
      1. Western Europe
      2. Eastern Europe
    4. Asia Pacific
      1. Japan
      2. China
      3. India
      4. Australia
      5. Republic of Korea
      6. Rest of Asia Pacific
    5. The Middle East & Africa
      1. United Arab Emirates
      2. Saudi Arabia
      3. Rest of the Middle East & Africa
    6. Chapter 10 Company Landscape
    7. Introduction
    8. Market Share Analysis
    9. Key Development & Strategies
      1. Key Developments
    10. Chapter 11 Company Profiles
    11. Abbott Laboratories
      1. Company Overview
      2. Product Overview
      3. Financials
      4. SWOT Analysis
    12. Therapath LLC
      1. Company Overview
      2. Product Overview
      3. Financial Overview
      4. Key Developments
      5. SWOT Analysis
    13. ARUP Laboratories
      1. Company Overview
      2. Product Overview
      3. Financial Overview
      4. Key Development
      5. SWOT Analysis
    14. Laboratory Corporation of America Holdings
      1. Company Overview
      2. Product/Business Segment Overview
      3. Financial Overview
      4. Key Development
      5. SWOT Analysis
    15. F. Hoffmann-La Roche Ltd
      1. Company Overview
      2. Product Overview
      3. Financial overview
      4. Key Developments
    16. Danaher Corporation
      1. Company Overview
      2. Product Overview
      3. Financial Overview
      4. Key Developments
    17. Quest Diagnostics Incorporated
      1. Overview
      2. Product Overview
      3. Financials
      4. Key Developments
      5. SWOT Analysis
    18. NeoGenomics Laboratories
      1. Company Overview
      2. Product/Business Segment Overview
      3. Financial Overview
      4. Key Development
      5. SWOT Analysis
    19. Agilent Technologies Inc.
      1. Company Overview
      2. Product Overview
      3. Financial overview
      4. Key Developments
    20. Others
    21. Chapter 12 MRFR Conclusion
    22. Key Findings
      1. From CEO’s View Point
      2. Unmet Needs of the Market
    23. Key Companies to Watch
    24. Prediction of Pharmaceutical industry
    25. Chapter 13 Appendix
  6. LIST OF TABLES
  7. Neuropathology Industry Synopsis, 2020 – 2027
  8. Neuropathology Market Estimates and Forecast, 2020 – 2027, (USD Million)
  9. Neuropathology Market by Region, 2020 – 2027, (USD Million)
  10. Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
  11. Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
  12. Neuropathology Market by End Users, 2020 – 2027, (USD Million)
  13. North America Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
  14. North America Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
  15. North America Neuropathology Market by End Users, 2020 – 2027, (USD Million)
  16. US Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
  17. US Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
  18. US Neuropathology Market by End Users, 2020 – 2027, (USD Million)
  19. Canada Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
  20. Canada Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
  21. Canada Neuropathology Market by End Users, 2020 – 2027, (USD Million)
  22. South America Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
  23. South America Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
  24. South America Neuropathology Market by End Users, 2020 – 2027, (USD Million)
  25. Europe Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
  26. Europe Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
  27. Europe Neuropathology Market by End Users, 2020 – 2027, (USD Million)
  28. Western Europe Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
  29. Western Europe Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
  30. Western Europe Neuropathology Market by End Users, 2020 – 2027, (USD Million)
  31. Eastern Europe Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
  32. Eastern Europe Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
  33. Eastern Europe Neuropathology Market by End Users, 2020 – 2027, (USD Million)
  34. Asia Pacific Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
  35. Asia Pacific Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
  36. Asia Pacific Neuropathology Market by End Users, 2020 – 2027, (USD Million)
  37. Middle East & Africa Neuropathology Market by Diagnosis, 2020 – 2027, (USD Million)
  38. Middle East & Africa Neuropathology Market by Treatment, 2020 – 2027, (USD Million)
  39. Middle East & Africa Neuropathology Market by End Users, 2020 – 2027, (USD Million)
  40. LIST OF FIGURES
  41. Research Process
  42. Segmentation for Neuropathology Market
  43. Segmentation Market Dynamics for Neuropathology Market
  44. Global Neuropathology Market Share, by Diagnosis 2020
  45. Global Neuropathology Market Share, by Treatment 2020
  46. Global Neuropathology Market Share, by End Users, 2020
  47. Global Neuropathology Market Share, by Region, 2020
  48. North America Neuropathology Market Share, by Country, 2020
  49. Europe Neuropathology Market Share, by Country, 2020
  50. Asia Pacific Neuropathology Market Share, by Country, 2020
  51. Middle East & Africa Neuropathology Market Share, by Country, 2020
  52. Global Neuropathology Market: Company Share Analysis, 2020 (%)
  53. Abbott Laboratories.: Key Financials
  54. Abbott Laboratories, Inc.: Segmental Revenue
  55. Abbott Laboratories.: Geographical Revenue
  56. Therapath LLC: Key Financials
  57. Therapath LLC: Segmental Revenue
  58. Therapath LLC: Geographical Revenue
  59. ARUP Laboratories: Key Financials
  60. ARUP Laboratories: Segmental Revenue
  61. ARUP Laboratories: Geographical Revenue
  62. Laboratory Corporation of America Holdings: Key Financials
  63. Laboratory Corporation of America Holdings: Segmental Revenue
  64. Laboratory Corporation of America Holdings: Geographical Revenue
  65. F. Hoffmann-La Roche Ltd: Key Financials
  66. F. Hoffmann-La Roche Ltd: Segmental Revenue
  67. F. Hoffmann-La Roche Ltd: Geographical Revenue
  68. Danaher Corporation: Key Financials
  69. Danaher Corporation: Segmental Revenue
  70. Danaher Corporation: Geographical Revenue
  71. Quest Diagnostics Incorporated: Key Financials
  72. Quest Diagnostics Incorporated: Segmental Revenue
  73. Quest Diagnostics Incorporated: Geographical Revenue
  74. NeoGenomics Laboratories: Key Financials
  75. NeoGenomics Laboratories: Segmental Revenue
  76. NeoGenomics Laboratories: Geographical Revenue
  77. Agilent Technologies Inc: Key Financials
  78. Agilent Technologies Inc: Segmental Revenue
  79. Agilent Technologies Inc: Geographical Revenue

Neuropathology Market Segmentation

Market Segmentation Overview

  • Detailed segmentation data will be available in the full report
  • Comprehensive analysis by multiple parameters
  • Regional and country-level breakdowns
  • Market size forecasts by segment
Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓